In this study, the authors analyzed the efficacy and safety of direct oral anticoagulants in patients treated for myeloproliferative neoplasms. Results did not show a significant difference in thrombotic or hemorrhagic events in patients treated with low-dose aspirin or direct oral anticoagulants.
Int J Hematol